Updated:
EMAlternatives
EMAlternatives is a private equity fund of funds based in Washington, founded 2007; the Altss profile covers its classification, headquarters, registration,...
EMAlternatives
EMAlternatives, founded in 2007, was a US-based fund of funds manager focused on private equity investments in biotech and life sciences.
General information
Firm type
Private Equity Fund of Funds
Year founded
2007
Location
Region
North America
Country
United States
City
Washington
Corporate office
Washington, DC, United States
Sector focus
Frequently asked questions
How does EMAlternatives source and select the underlying fund managers?
EMAlternatives sources local general partners through on-the-ground research networks concentrated in Latin America, Southeast Asia, Africa, and Eastern Europe. The firm performs in-country operational due diligence on fund managers that most foreign limited partners cannot access directly, evaluating track records, currency-hedging practices, and alignment of interests in markets with wide performance dispersion between top- and bottom-quartile managers.
What types of private equity strategies does EMAlternatives allocate to?
The firm commits to underlying funds spanning venture capital (including seed and early-stage), growth equity, buyouts, and special situations. Its portfolio blends technology venture funds in markets like Indonesia and Nigeria, mid-market buyout vehicles targeting Latin American industrial supply chains, and distressed-debt and carve-out managers active in Central and Eastern Europe.
Is EMAlternatives structured as a single fund or a series of vehicles?
EMAlternatives operates as a fund-of-funds manager, meaning it does not invest directly in companies. Instead, it pools commitments from institutional investors and family offices into fund vehicles that allocate across a portfolio of local emerging-market private equity funds. The firm has not publicly detailed the specific number or vintage years of its commingled vehicles.
Who runs investment decisions at EMAlternatives?
EMAlternatives has not publicly named its investment committee members or managing principals. The firm maintains a low public profile, and no detailed information on its leadership team has been disclosed through its website or other official channels.
How does EMAlternatives handle currency risk across its emerging-market fund commitments?
The firm deliberately layers currency-hedged and dollar-denominated fund structures where available within its portfolio. This reflects the hard-currency return expectations typical of the institutional and family-office limited partners that EMAlternatives serves, for whom local-currency depreciation in emerging markets represents a material return risk.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: